Oxcarbazepine Therapy in Very Young Children: A Single-Center Clinical Experience

Pediatric Neurology

Volumn 35, Issue 3, 2006, Pages 173-176

  Kothare, Sanjeev V ^a   Mostofi, Navid ^a   Khurana, Divya S ^a   Mohsem, Bashar ^a   Melvin, Joseph J ^a   Hardison, Huntley H ^a   Valencia, Ignacio ^a   Legido, Agustin ^a  

^a ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; OXCARBAZEPINE; PHENOBARBITAL; VALPROIC ACID;

ANTICONVULSANT THERAPY; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CLINICAL ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DROWSINESS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; DRUG TOLERABILITY; FEMALE; GRAND MAL SEIZURE; HUMAN; INFANT; LENNOX GASTAUT SYNDROME; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; TONIC CLONIC SEIZURE; TREATMENT OUTCOME;

AGE FACTORS; ANTICONVULSANTS; CARBAMAZEPINE; CHILD, PRESCHOOL; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33747884235     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2006.03.003     Document Type: Article

References (20)

1. Shinnar S., and Pellock J.M. Update on the epidemiology and prognosis of pediatric epilepsy. J Child Neurol 17 Suppl. 1 (2002) S4-S17
2. Bourgeois B.F. New antiepileptic drugs in children. Which ones for which seizures?. Clin Neuropharmacol 23 (2000) 119-132
3. Loring D.W., and Meador K.J. Cognitive side effects of antiepileptic drugs in children. Neurology 62 (2004) 872-877
4. Aman M.G., Werry J.S., Paxton J.W., and Turbott S.H. Effect of sodium valproate on psychomotor performance in children as a function of dose, fluctuations in concentration, and diagnosis. Epilepsia 28 (1987) 115-124
5. Seidel W.T., and Mitchell W.G. Cognitive and behavioral effects of carbamazepine in children. Data from benign rolandic epilepsy. J Child Neurol 14 (1999) 716-723
6. Forsythe I., Butler R., Berg I., and McGuire R. Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate. Dev Med Child Neurol 33 (1991) 524-534
7. Farwell J.R., Lee Y.J., Hirtz D.G., Sulzbacher S.I., Ellenberg J.H., and Nelson K.B. Phenobarbital for febrile seizures-effects on intelligence and on seizure recurrence. N Engl J Med 322 (1990) 364-369
8. Sulzbacher S., Farwell J.R., Temkin N., Lu A.S., and Hirtz D.G. Late cognitive effects of early treatment with phenobarbital. Clin Pediatrics 38 (1999) 387-394
9. Aldenkamp A.P., De K.M., and Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia 44 Suppl. 4 (2003) 21-29
10. Aldenkamp A.P., Donati F., Mangat S., and Karolchyk M. Cognitive function in children and adolescents with partial seizures. An open label randomized active control, multicenter trial of oxcarbazepine. Epilepsia 45 Suppl. 7 (2004) S131
11. Gaily E., Granstrom M.L., and Liukkonen E. Oxcarbazepine in the treatment of early childhood epilepsy. J Child Neurol 12 (1997) 496-498
12. Serdaroglu G., Kurul S., Tutuncuoglu S., Dirik E., and Sarioglu B. Oxcarbazepine in the treatment of childhood epilepsy. Pediatr Neurol 28 (2003) 37-41
13. Guerreiro M.M., Vigonius U., Pohlmann H., et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res 27 (1997) 205-213
14. Glauser T.A., Nigro M., Sachdeo R., et al., The Oxcarbazepine Pediatric Study Group. Adjunctive therapy with oxcarbazepine in children with partial seizures. Neurology 54 (2000) 2237-2244
15. Rey E., Bulteau C., Motte J., et al. Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy. J Clin Pharmacol 44 (2004) 1290-1300
16. Bourgeois B.F., and D'Souza J. Safety and tolerability of oxcarbazepine in children with epilepsy. Epilepsia 45 Suppl. 7 (2004) S275
17. Cukiert A., Sachdeo R., Ayala R., et al. A multicenter, rater-blind, randomized, age-stratified, parallel-group study comparing high- versus low-dose oxcarbazepine monotherapy in pediatric patients with inadequately controlled partial seizures. Epilepsia 45 Suppl. 7 (2004) 318
18. Northam R., Duchowny M., Mangat S., Jiang H., and Sturm Y. Oxcarbazepine shows good tolerability and safety profiles over 6 months in infants and very young children with partial epilepsy. Neurology 62 (2004) A117
19. Piña-Garza J., Espinoza R., Nordli D., et al. Oxcarbazepine adjunctive therapy in infants and young children with partial seizures. Neurology 64 Suppl. 1 (2005) A187
20. Glauser T.A. Behavioral and psychiatric adverse events associated with antiepileptic drugs commonly used in pediatric patients. J Child Neurol 19 Suppl. 1 (2004) S25-S38